CLASSIFICATION OF CANCER CHEMOTHERAPEUTIC DRUGS ACCORDING TO THEIR ABILITY TO POTENTIATE CONTACT SENSITIVITY TO DINITROFLUOROBENZENE

被引：0
|
作者：
BENEFRAIM, S [1 ]
GAL, T [1 ]
ZIMBER, C [1 ]
WEISS, DW [1 ]
机构：
[1] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,LAUTENBERG CTR GEN & TUMOR IMMUNOL,DEPT HUMAN MICROBIOL,IL-91010 JERUSALEM,ISRAEL
来源：
ANTICANCER RESEARCH | 1986年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1341 / 1346
页数：6
相关论文
共 30 条
  • [21] Suppression of the vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer
    Kamiya, Sakura
    Nakamori, Yuna
    Takasawa, Akira
    Takasawa, Kumi
    Kyuno, Daisuke
    Ono, Yusuke
    Magara, Kazufumi
    Osanai, Makoto
    ONCOLOGY REPORTS, 2023, 49 (05)
  • [22] EFFECT OF NEGATIVE REGULATION OF MIR-217 ON HETEROMUCIN (MTDH) EXPRESSION ON THE SENSITIVITY OF CHEMOTHERAPEUTIC DRUGS IN PROSTATE CANCER PC-3 CELLS
    Zhang, Tao
    Wu, Zonglin
    Geng, He
    ACTA MEDICA MEDITERRANEA, 2020, 36 (06): : 3513 - 3517
  • [23] Effects of inhibition of Raf/MEK/ERK and Pl3K/AKT signaling pathways on sensitivity of prostatic cancer cells to chemotherapeutic drugs
    Kragel, Christopher
    Chappell, William H.
    McCubrey, James
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (11) : 1173 - 1173
  • [24] PREVENTION BY THE MER TUBERCLE BACILLUS FRACTION OF IMMUNOSUPPRESSION INDUCED BY CANCER CHEMOTHERAPEUTIC-AGENTS .3. CONTACT HYPERSENSITIVITY TO DINITROFLUOROBENZENE IN MICE TREATED WITH METHOTREXATE, 5-FLUOROURACIL OR CYCLOPHOSPHAMIDE, OR EXPOSED TO DINITROBENZENE-SULFONATE
    ZIMBER, C
    BENEFRAIM, S
    WEISS, DW
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1981, 10 (2-3) : 147 - 155
  • [25] IN-VITRO TESTS TO DETERMINE SENSITIVITY OF SOLID MALIGNANT TUMORS TO ACTION OF CYTOSTATIC DRUGS - METHOD OF ESTABLISHING SUITABLE COMBINED SURGICAL AND CHEMOTHERAPEUTIC PROCEDURES IN TREATMENT OF CANCER
    KUMMER, D
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1971, 329 : 236 - &
  • [26] HER2 expression levels of breast cancer cell lines grown in 2D and 3D cell culture and sensitivity to chemotherapeutic drugs
    Azimi, Tayebeh
    Dwek, Miriam
    Markiv, Anatoliy
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 192 - 193
  • [27] GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals
    Abrams, Stephen L.
    Akula, Shaw M.
    Meher, Akshaya K.
    Steelman, Linda S.
    Gizak, Agnieszka
    Duda, Przemyslaw
    Rakus, Dariusz
    Martelli, Alberto M.
    Ratti, Stefano
    Cocco, Lucio
    Montalto, Giuseppe
    Cervello, Melchiorre
    Ruvolo, Peter
    Libra, Massimo
    Falzone, Luca
    Candido, Saverio
    McCubrey, James A.
    CELLS, 2021, 10 (04)
  • [28] miR-92b-3p Regulates Cell Cycle and Apoptosis by Targeting CDKN1C, Thereby Affecting the Sensitivity of Colorectal Cancer Cells to Chemotherapeutic Drugs
    Zhao, Fangqing
    Yang, Zhongmin
    Gu, Xiaofan
    Feng, Lixing
    Xu, Mingshi
    Zhang, Xiongwen
    CANCERS, 2021, 13 (13)
  • [29] Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
    Lambertini, Matteo
    Blondeaux, Eva
    Bisagni, Giancarlo
    Mura, Silvia
    De Placido, Sabino
    De Laurentiis, Michelino
    Fabi, Alessandra
    Rimanti, Anita
    Michelotti, Andrea
    Mansutti, Mauro
    Russo, Antonio
    Montemurro, Filippo
    Frassoldati, Antonio
    Durando, Antonio
    Gori, Stefania
    Turletti, Anna
    Tamberi, Stefano
    Urracci, Ylenia
    Fregatti, Piero
    Razeti, Maria Grazia
    Caputo, Roberta
    De Angelis, Carmine
    Sanna, Valeria
    Gasparini, Elisa
    Agostinetto, Elisa
    de Azambuja, Evandro
    Poggio, Francesca
    Boni, Luca
    Del Mastro, Lucia
    ECLINICALMEDICINE, 2023, 59
  • [30] Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
    McCubrey, James A.
    Meher, Akshaya K.
    Akula, Shaw M.
    Abrams, Stephen L.
    Steelman, Linda S.
    LaHair, Michelle M.
    Franklin, Richard A.
    Martelli, Alberto M.
    Ratti, Stefano
    Cocco, Lucio
    Barbaro, Fulvio
    Duda, Przemyslaw
    Gizak, Agnieszka
    AGING-US, 2022, 14 (08): : 3365 - 3386
123